Please select the option that best describes you:

Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?  

For example, if a patient with intermediate risk prostate cancer has a high risk Decipher score (10 year risk of metastasis with standard therapy of >15%), but is low risk by ArteraAI and is biomarker negative, would you add ADT to RT?



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Community Health Network
Thanks for the thorough explanation 
Radiation Oncologist at Beth Israel Deaconess Medical Center/Harvard Medical School
Please disclose possible conflict of interests
Radiation Oncologist at Case Western Reserve University/ University Hospitals Seidman Cancer Center
None with any companies discussed. Hence, why none...
Radiation Oncologist at UMass Memorial Medical Group
Exceptionally well-written and insightful answer, ...
Sign in or Register to read more